Abstract Details

Title Reducing Complications in Hospitalized Parkinson's Patients

Topic Movement Disorders

Presentation(s) P3 - Poster Session 3 (5:30 PM-6:30 PM)

Poster/Presentation
Number 10-038

Objective Evaluate an inpatient intervention to reduce rates of hospital related complications in patients with Parkinson’s disease (PD).

Background Several interventions have been suggested to reduce known inpatient complications in hospitalized PD patients but there are no data driven recommendations currently reported.

Design/Methods A hospital wide alert system was incorporated into the EMR of Dignity Health affiliated hospitals in Arizona. Extensive in-services were done with providers and staff. Charts of subjects with PD admitted 6 months before and after the intervention were reviewed for baseline demographics, compliance with the intervention, and outcomes.

Results 73 patients (mean age 73 years, mean disease duration 7.2 ± 9.1 years) in the pre-intervention group, 103 patients (mean age 72 years, mean disease duration 7.0 ± 6.4 years) in the post-intervention group were included. There were no significant differences among reasons for admission, admission to neurological vs non-neurological floor, or the service the patients were admitted to between the groups. The percentage of patients for whom contra-indicated medications ordered decreased from 42.5% to 17.5% (p<0.001). Medication administration within 30 minutes of scheduled time went from 36% to 53%, and doses given over 30 minutes went from 46% to 39% (p=0.068). Medications ordered by home schedule was 42.9% vs 54.7% (p=0.131) before and after the intervention. Length of stay was 5.3 vs 5.2 days (p=0.896) and mean number of complications was 0.38 vs 0.37 (p=0.864).

Conclusions An intervention involving EMR alerts and in-service didactics decreased the frequency of contraindicated medications ordered in hospitalized PD patients.

Authors/Disclosures
Sana Aslam, DO (University of Colorado) PRESENTER	Dr. Aslam has nothing to disclose.
	No disclosure on file
	No disclosure on file
Holly A. Shill, MD, FAAN (Barrow Neurology Clinics)	Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.

��ɫ��

��ɫ��